Shortages of Essential Generic Drugs with Limited Competition.
作者信息
Martin Matthew J, Rome Benjamin N, Kesselheim Aaron S, Lalani Hussain S
机构信息
Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
出版信息
J Gen Intern Med. 2024 Nov;39(14):2871-2874. doi: 10.1007/s11606-024-08937-x. Epub 2024 Jul 19.
Abstract
摘要
相似文献
1
Shortages of Essential Generic Drugs with Limited Competition.基本通用药物短缺且竞争有限。
J Gen Intern Med. 2024 Nov;39(14):2871-2874. doi: 10.1007/s11606-024-08937-x. Epub 2024 Jul 19.
2
Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.药品短缺的预测因素及其与仿制药价格的关联：一项回顾性队列研究。
Value Health. 2018 Nov;21(11):1286-1290. doi: 10.1016/j.jval.2018.04.1826. Epub 2018 May 18.
3
The Evolution of Supply and Demand in Markets for Generic Drugs.仿制药市场的供需演变。
Milbank Q. 2021 Sep;99(3):828-852. doi: 10.1111/1468-0009.12517. Epub 2021 Jun 1.
4
High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.高通用药品价格与市场竞争：一项回顾性队列研究。
Ann Intern Med. 2017 Aug 1;167(3):145-151. doi: 10.7326/M16-1432. Epub 2017 Jul 4.
5
Generic Drugs in the United States: Policies to Address Pricing and Competition.美国的仿制药：解决定价和竞争问题的政策。
Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10.
6
[Competition for the promotion of essential generic drugs in Africa].[非洲基本通用药物推广竞争]
Sante. 1999 Jan-Feb;9(1):47-52.
7
Effects of Generic Entry on Market Shares and Prices of Originator Drugs: Evidence from Chinese Pharmaceutical Market.仿制药进入对原研药市场份额和价格的影响：来自中国药品市场的证据。
Pharmacoecon Open. 2025 Mar 19. doi: 10.1007/s41669-025-00570-6.
8
Immunogenicity of Generic Peptide Impurities: Current Orthogonal Approaches.仿制药肽杂质的免疫原性：当前的正交方法
Pharm Res. 2025 Mar 24. doi: 10.1007/s11095-025-03843-1.
9
[Policies encouraging price competition in the generic drug market: Lessons from the European experience].[鼓励仿制药市场价格竞争的政策：欧洲经验教训]
Gac Sanit. 2010 May-Jun;24(3):193-9. doi: 10.1016/j.gaceta.2009.12.003. Epub 2010 Mar 1.
10
Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety.解决仿制药缺乏竞争问题，以提高医疗质量和安全。
J Gen Intern Med. 2018 Nov;33(11):2005-2007. doi: 10.1007/s11606-018-4548-x. Epub 2018 Aug 8.
本文引用的文献
1
Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists.药物短缺期间的配给情况和严重程度：一项全国范围内卫生系统药师的调查。
JAMA Intern Med. 2019 May 1;179(5):710-711. doi: 10.1001/jamainternmed.2018.8251.
2
Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.药品短缺的预测因素及其与仿制药价格的关联：一项回顾性队列研究。
Value Health. 2018 Nov;21(11):1286-1290. doi: 10.1016/j.jval.2018.04.1826. Epub 2018 May 18.
3
Changes in Drug Pricing After Drug Shortages in the United States.美国药品短缺后药品价格的变化。
Ann Intern Med. 2019 Jan 1;170(1):74-76. doi: 10.7326/M18-1137. Epub 2018 Sep 18.
Zotero 插件